Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07
Clinical trial NCT02434666 · COMPLETED
Trial details
- NCT number
- NCT02434666
- Sponsor
- Chase Pharmaceuticals Corporation, an affiliate of Allergan plc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-08
- Primary completion
- 2016-10-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.